Rajesh P. Ringe

2.2k total citations
46 papers, 1.2k citations indexed

About

Rajesh P. Ringe is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Rajesh P. Ringe has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Virology, 20 papers in Infectious Diseases and 16 papers in Molecular Biology. Recurrent topics in Rajesh P. Ringe's work include HIV Research and Treatment (30 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Immune Cell Function and Interaction (10 papers). Rajesh P. Ringe is often cited by papers focused on HIV Research and Treatment (30 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Immune Cell Function and Interaction (10 papers). Rajesh P. Ringe collaborates with scholars based in India, United States and Netherlands. Rajesh P. Ringe's co-authors include John P. Moore, Albert Cupo, Rogier W. Sanders, Andrew B. Ward, Per Johan Klasse, Ian A. Wilson, Anila Yasmeen, Jayanta Bhattacharya, Gabriel Ozorowski and Ronald Derking and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Rajesh P. Ringe

45 papers receiving 1.2k citations

Peers

Countries citing papers authored by Rajesh P. Ringe

Since Specialization

Citations

This map shows the geographic impact of Rajesh P. Ringe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh P. Ringe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh P. Ringe more than expected).

Fields of papers citing papers by Rajesh P. Ringe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh P. Ringe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh P. Ringe. The network helps show where Rajesh P. Ringe may publish in the future.

Co-authorship network of co-authors of Rajesh P. Ringe

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh P. Ringe. A scholar is included among the top collaborators of Rajesh P. Ringe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh P. Ringe. Rajesh P. Ringe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stabilizing Prefusion SARS-CoV-2 Spike by Destabilizing the Postfusion Conformation 2025 ·Vaccines ·(unknown), Randhir Singh, Raju S Rajmani, (unknown), Rajesh P. Ringe, Raghavan Varadarajan	2
2	Scalable bioprocess for high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells 2024 ·Process Biochemistry ·Sneha Singh, (unknown), (unknown), (unknown), Geetika Verma, (unknown), (unknown), Reetesh Kumar, Rajesh P. Ringe, Shashank Tripathi, Nimesh Gupta, Ravi P.N. Mishra	3
3	SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Rajesh P. Ringe, Mahak Sharma, Amit Tuli	19
4	Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity 2023 ·Journal of Virology ·(unknown), (unknown), (unknown), (unknown), Randhir Singh, (unknown), Samreen Siddiqui, Akansha Tyagi, (unknown), Krishan Gopal Thakur, Rajesh Pandey, Raghavan Varadarajan, Rajesh P. Ringe	10
5	Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern 2023 ·Viruses ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), S. K. Singh Pandey, Randhir Singh, Somnath Dutta, Rajesh P. Ringe, Raghavan Varadarajan	10
6	Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice 2023 ·Pharmaceutics ·(unknown), (unknown), Randhir Singh, Raju S Rajmani, (unknown), (unknown), Harry Kleanthous, Rajesh P. Ringe, Patrice Dubois, Raghavan Varadarajan	2
7	Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants 2023 ·npj Vaccines ·(unknown), (unknown), Raju S Rajmani, Randhir Singh, (unknown), (unknown), (unknown), (unknown), M. Seetharama Bhat, (unknown), S. K. Singh Pandey, Aurélie Jory, (unknown), Harry Kleanthous, Patrice Dubois, Rajesh P. Ringe, Raghavan Varadarajan	3
8	Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization 2023 ·PLoS Pathogens ·Rajesh P. Ringe, Philippe Colin, Gabriel Ozorowski, Joel D. Allen, Anila Yasmeen, Gemma E. Seabright, Jeong Hyun Lee, Aleksandar Antanasijevic, Kimmo Rantalainen, Thomas J. Ketas, John P. Moore, Andrew B. Ward, Max Crispin, Per Johan Klasse	5
9	UVC-Based Air Disinfection Systems for Rapid Inactivation of SARS-CoV-2 Present in the Air 2023 ·Pathogens ·Harry Garg, Rajesh P. Ringe, (unknown), (unknown), (unknown), (unknown), Ajay Kumar, Kishor S. Kulkarni, Kanika Bansal, Prabhu B. Patil, Tabish Alam, Nagesh Babu Balam, Chandan Swaroop Meena, Krishan Gopal Thakur, Ashok Kumar, Ashwani Kumar	10
10	Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization 2023 ·Retrovirology ·Philippe Colin, Rajesh P. Ringe, Anila Yasmeen, Gabriel Ozorowski, Thomas J. Ketas, Wen-Hsin Lee, Andrew B. Ward, John P. Moore, Per Johan Klasse	4
11	A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2 2022 ·Virus Research ·Anindya Sarkar, (unknown), Charandeep Singh, (unknown), (unknown), (unknown), (unknown), Anshul Sharma, Deepjyoti Kumar Das, Dipak Dutta, Krishan Gopal Thakur, Angshuman Bagchi, (unknown), K. P. Das, Rajesh P. Ringe, Sampa Das	9
12	Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities 2021 ·Retrovirology ·Ranajoy Mullick, (unknown), (unknown), (unknown), Madhuri Thakar, Seema Sahay, Rajesh P. Ringe, (unknown), Ajit Patil, (unknown), Kailapuri G. Murugavel, Aylur K. Srikrishnan, Rajat Goyal, Devin Sok, Jayanta Bhattacharya	3
13	Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2 2020 ·Computational and Structural Biotechnology Journal ·(unknown), (unknown), Sunil Kumar, Rajesh P. Ringe, Raman Parkesh	28
14	Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C 2016 ·PLoS Pathogens ·Per Johan Klasse, Celia C. LaBranche, Thomas J. Ketas, Gabriel Ozorowski, Albert Cupo, Pavel Pugach, Rajesh P. Ringe, Michael Golabek, Marit J. van Gils, Miklós Guttman, Kelly K. Lee, Ian A. Wilson, Salvatore T. Butera, Andrew B. Ward, David C. Montefiori, Rogier W. Sanders, John P. Moore	99
15	Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers 2015 ·Cell Reports ·Laura K. Pritchard, Snežana Vasiljević, Gabriel Ozorowski, Gemma E. Seabright, Albert Cupo, Rajesh P. Ringe, Helen J. Kim, Rogier W. Sanders, Katie J. Doores, Dennis R. Burton, Ian A. Wilson, Andrew B. Ward, John P. Moore, Max Crispin	96
16	Characterization of Circulating HIV Type 1 env Genes in Plasma of Two Antiretroviral-Naive Slow Progressing Patients with Broad Neutralizing Antibody Response with Evidence of Recombination 2011 ·AIDS Research and Human Retroviruses ·(unknown), Rajesh P. Ringe, Ajit Patil, Ramesh Paranjape, Jayanta Bhattacharya	7
17	Evidence of extended alternate coreceptor usage by HIV-1 clade C envelope obtained from an Indian patient 2011 ·Virus Research ·Lavina Gharu, Rajesh P. Ringe, Jayanta Bhattacharya	4
18	Short Communication: Evidence of HIV Type 1 Clade C env Clones Containing Low V3 Loop Charge Obtained from an AIDS Patient in India That Uses CXCR6 and CCR8 for Entry in Addition to CCR5 2010 ·AIDS Research and Human Retroviruses ·Lavina Gharu, Rajesh P. Ringe, (unknown), Ajit Patil, Jayanta Bhattacharya	3
19	Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C envclones obtained at different time points from antiretroviral naïve Indian patients with recent infection 2010 ·Retrovirology ·Rajesh P. Ringe, Madhuri Thakar, Jayanta Bhattacharya	28
20	HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop 2009 ·Virus Research ·Lavina Gharu, Rajesh P. Ringe, (unknown), Ramesh Paranjape, Jayanta Bhattacharya	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact